MedPath

Study held to see the effect of Navkarshika Tablet in management of urticaria.

Phase 2
Conditions
Health Condition 1: L509- Urticaria, unspecified
Registration Number
CTRI/2023/03/050928
Lead Sponsor
Dr.Neha Saini
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with the sign and symptoms of Shitapitta like pruritis(Kandu), burning sensation(Daha), pricking pain(Toda), wheals/hives(Mandalotpati), Swelling as if bitten by the wasp (Varati Dansha Sansthan Sopha).

Exclusion Criteria

1) Patients with major pathologies like

Malignancy , TB will be excluded from

this study

2) History of Anaphylaxis to medicine

3) History of Angioedema

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
reduction of symptoms like Swelling as if bitten by the wasp, Wheals,itching , pricking pain.Timepoint: 14 days study with follow ups (0,7,14)
Secondary Outcome Measures
NameTimeMethod
To study the new etiological factors in present era if any.Timepoint: 14 days study with follow ups.
© Copyright 2025. All Rights Reserved by MedPath